X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3999) 3999
Book Review (914) 914
Publication (177) 177
Newsletter (20) 20
Book Chapter (9) 9
Conference Proceeding (8) 8
Magazine Article (6) 6
Transcript (3) 3
Book / eBook (2) 2
Newspaper Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3714) 3714
humans (2889) 2889
epoprostenol - therapeutic use (1788) 1788
male (1769) 1769
female (1472) 1472
animals (1374) 1374
hypertension, pulmonary - drug therapy (1095) 1095
adult (917) 917
middle aged (894) 894
prostacyclin (888) 888
abridged index medicus (719) 719
antihypertensive agents - therapeutic use (716) 716
pulmonary hypertension (706) 706
epoprostenol - analogs & derivatives (636) 636
epoprostenol - pharmacology (577) 577
rats (540) 540
epoprostenol - administration & dosage (539) 539
cardiac & cardiovascular systems (520) 520
hypertension, pulmonary - physiopathology (515) 515
epoprostenol (504) 504
aged (503) 503
pharmacology & pharmacy (501) 501
respiratory system (476) 476
vasodilator agents - therapeutic use (446) 446
treatment outcome (417) 417
therapy (412) 412
epoprostenol - metabolism (386) 386
hypertension (378) 378
epoprostenol - biosynthesis (371) 371
platelet aggregation - drug effects (344) 344
survival (341) 341
pulmonary arterial hypertension (336) 336
iloprost (294) 294
hypertension, pulmonary - etiology (283) 283
dose-response relationship, drug (271) 271
continuous intravenous epoprostenol (269) 269
time factors (269) 269
blood pressure - drug effects (267) 267
antihypertensive agents - administration & dosage (262) 262
drug therapy, combination (260) 260
hypertension, pulmonary - diagnosis (251) 251
drug therapy (250) 250
hemodynamics - drug effects (249) 249
prostaglandins - therapeutic use (239) 239
care and treatment (233) 233
nitric oxide (226) 226
medicine, general & internal (225) 225
arterial-hypertension (224) 224
in vitro techniques (224) 224
double-blind (222) 222
epoprostenol - adverse effects (215) 215
bosentan (212) 212
dogs (208) 208
infusions, intravenous (207) 207
platelet aggregation inhibitors - therapeutic use (206) 206
treprostinil (205) 205
peripheral vascular disease (204) 204
epoprostenol - physiology (193) 193
sildenafil (190) 190
nitric-oxide (189) 189
prostaglandins (189) 189
surgery (189) 189
hemodynamics (188) 188
sulfonamides - therapeutic use (185) 185
hypertension, pulmonary - therapy (180) 180
administration, inhalation (179) 179
adolescent (177) 177
disease (176) 176
inhaled iloprost (169) 169
mice (168) 168
research (167) 167
endothelin receptor antagonists (166) 166
rabbits (166) 166
inhaled nitric-oxide (165) 165
aspirin - therapeutic use (162) 162
retrospective studies (161) 161
sildenafil citrate (161) 161
epoprostenol - blood (159) 159
prognosis (159) 159
blood platelets - drug effects (158) 158
clinical trials as topic (158) 158
child (156) 156
administration, oral (152) 152
vascular resistance - drug effects (152) 152
prostacyclin analog (150) 150
critical care medicine (145) 145
pregnancy (144) 144
placebo-controlled trial (141) 141
transplantation (141) 141
double-blind method (140) 140
health aspects (140) 140
risk factors (139) 139
vasodilator agents - administration & dosage (138) 138
hypertension, pulmonary - complications (136) 136
familial primary pulmonary hypertension (135) 135
endothelium (134) 134
piperazines - therapeutic use (134) 134
antihypertensive agents - adverse effects (133) 133
hypertension, pulmonary - mortality (133) 133
calcium channel blockers - therapeutic use (132) 132
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3625) 3625
Japanese (79) 79
German (69) 69
French (64) 64
Polish (40) 40
Spanish (37) 37
Russian (31) 31
Italian (27) 27
Chinese (25) 25
Serbian (6) 6
Turkish (6) 6
Dutch (4) 4
Hungarian (4) 4
Romanian (4) 4
Bulgarian (2) 2
Danish (2) 2
Lithuanian (2) 2
Norwegian (2) 2
Portuguese (2) 2
Swedish (2) 2
Ukrainian (2) 2
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 08/2017, Volume 76, Issue 8, pp. 1327 - 1339
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new... 
Systemic Sclerosis | Cyclophosphamide | Treatment | Methotrexate | ORAL PROSTACYCLIN ANALOG | SCLERODERMA RENAL CRISIS | DIGITAL ULCERS | DOUBLE-BLIND TRIAL | PULMONARY ARTERIAL-HYPERTENSION | INTESTINAL BACTERIAL OVERGROWTH | INTRAVENOUS EPOPROSTENOL | RAYNAUDS-PHENOMENON SECONDARY | STANDARDIZED OPERATING PROCEDURES | RHEUMATOLOGY | STEM-CELL TRANSPLANTATION | Glucocorticoids - therapeutic use | Pyrazoles - therapeutic use | Humans | Gastrointestinal Diseases - etiology | Lung Diseases - therapy | Raynaud Disease - etiology | Hypertension, Pulmonary - therapy | Lung Diseases - etiology | Scleroderma, Systemic - therapy | Delphi Technique | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Raynaud Disease - therapy | Fingers | Scleroderma, Systemic - complications | Phosphodiesterase 5 Inhibitors - therapeutic use | Fluoxetine - therapeutic use | Ulcer - etiology | Ulcer - therapy | Europe | Rheumatology | Serotonin Uptake Inhibitors - therapeutic use | Hematopoietic Stem Cell Transplantation | Gastrointestinal Diseases - therapy | Prostaglandins I - therapeutic use | Pyrimidines - therapeutic use | Kidney Diseases - therapy | Kidney Diseases - etiology | Endothelin Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - etiology | Endothelin | Experts | Fluoxetine | Lung diseases | Clinical trials | Stem cell transplantation | Transplantation | Prostacyclin | Patients | Sclerosis | Literature reviews | Studies | Systemic sclerosis | Ulcers | Skin diseases | Scleroderma | Phosphodiesterase | Kidney transplantation | Index Medicus | Rheumatology and Autoimmunity | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Reumatologi och inflammation
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 6, pp. 1383 - 1390
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Seminars in Perinatology, ISSN 0146-0005, 2014, Volume 38, Issue 2, pp. 78 - 91
Abstract Persistent pulmonary hypertension of the newborn (PPHN) is a syndrome of failed circulatory adaptation at birth, seen in about 2/1000 live born... 
Neonatal and Perinatal Medicine | Systemic vasodilators | Pulmonary vascular resistance | Persistent fetal circulation | Hypoxic respiratory failure | Nitric oxide | PERSISTENT PULMONARY-HYPERTENSION | NATRIURETIC PEPTIDE | SOLUBLE GUANYLATE-CYCLASE | INHALED NITRIC-OXIDE | OBSTETRICS & GYNECOLOGY | SEROTONIN-REUPTAKE INHIBITORS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | IMPROVES OXYGENATION | FREQUENCY OSCILLATORY VENTILATION | PEDIATRICS | FETAL LAMBS | RESPIRATORY-FAILURE | Persistent Fetal Circulation Syndrome - therapy | Respiratory Distress Syndrome, Newborn - complications | Sulfones - therapeutic use | Respiration, Artificial - methods | Vasodilator Agents - therapeutic use | Oxygen Inhalation Therapy - nursing | Humans | Persistent Fetal Circulation Syndrome - etiology | Nitric Oxide - therapeutic use | Vascular Resistance - physiology | Hernia, Diaphragmatic - complications | Hernias, Diaphragmatic, Congenital | Sildenafil Citrate | Epoprostenol - therapeutic use | Alprostadil - therapeutic use | Meconium Aspiration Syndrome - complications | Oxygen Inhalation Therapy - methods | Purines - therapeutic use | Extracorporeal Membrane Oxygenation - methods | Infant, Newborn | Persistent Fetal Circulation Syndrome - physiopathology | Administration, Inhalation | Piperazines - therapeutic use | Pulmonary Surfactants - therapeutic use | Endothelium-Dependent Relaxing Factors - therapeutic use | Asphyxia Neonatorum - complications | Acute respiratory distress syndrome | Hernia | Vasodilators | Pulmonary hypertension | Index Medicus
Journal Article